Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials

Taro Kishi,1,* Shinji Matsunaga,1,2,* Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan; 2Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan *These authors c...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kishi T, Matsunaga S, Iwata N
Format: article
Langue:EN
Publié: Dove Medical Press 2018
Sujets:
Accès en ligne:https://doaj.org/article/3ec67a78498f4e618110e3ad6effe6c1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!